Tapestri Platform Cell and Gene Therapy Solutions

Cell and gene therapies are notoriously difficult to characterize. Yet, early and thorough characterization is key to advancing therapeutic programs quickly with minimal risk of safety issues or clinical holds. Whether a therapy utilizes gene transfer technologies or gene editing tools, both approaches result in heterogeneity. Some cells have the desired changes while others do not, and some may even have alterations that pose a safety risk. Learn more about how Mission Bio can help you characterize your cell and gene therapies better.

VIEW

brochure

Tapestri Single-Cell Multiple Myeloma Multiomics Solution

FLYER

brochure

Multiplex Samples by Antibody Hashing

FLYER

brochure

Multiplex Samples by Genotyping

FLYER

brochure

Publication Highlight: Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

FLYER

Tapestri Platform Cell and Gene Therapy Solutions

SHARE THIS PAGE